Spark Investment Management LLC Purchases 61,200 Shares of Nuvectra Corp (NVTR)
Spark Investment Management LLC lifted its position in shares of Nuvectra Corp (NASDAQ:NVTR) by 551.4% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 72,300 shares of the company’s stock after buying an additional 61,200 shares during the quarter. Spark Investment Management LLC owned approximately 0.51% of Nuvectra worth $1,484,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently bought and sold shares of NVTR. First Manhattan Co. bought a new stake in Nuvectra during the second quarter valued at about $102,000. Financial Architects Inc boosted its position in Nuvectra by 300.0% during the second quarter. Financial Architects Inc now owns 10,000 shares of the company’s stock valued at $205,000 after purchasing an additional 7,500 shares in the last quarter. Rhumbline Advisers bought a new stake in Nuvectra during the second quarter valued at about $275,000. Element Capital Management LLC bought a new stake in Nuvectra during the first quarter valued at about $200,000. Finally, JPMorgan Chase & Co. boosted its position in Nuvectra by 1,053.5% during the first quarter. JPMorgan Chase & Co. now owns 19,309 shares of the company’s stock valued at $251,000 after purchasing an additional 17,635 shares in the last quarter. 78.58% of the stock is currently owned by institutional investors and hedge funds.
Shares of NASDAQ NVTR opened at $21.18 on Friday. The company has a debt-to-equity ratio of 0.75, a quick ratio of 3.77 and a current ratio of 4.10. Nuvectra Corp has a fifty-two week low of $7.60 and a fifty-two week high of $23.66.
A number of equities research analysts recently weighed in on the company. Zacks Investment Research raised Nuvectra from a “sell” rating to a “hold” rating in a research report on Friday, June 15th. SunTrust Banks raised their price objective on Nuvectra to $27.00 and gave the company a “buy” rating in a research report on Thursday, June 21st. BidaskClub downgraded Nuvectra from a “strong-buy” rating to a “buy” rating in a report on Tuesday, July 3rd. ValuEngine raised Nuvectra from a “hold” rating to a “buy” rating in a report on Saturday, June 2nd. Finally, JMP Securities raised their price target on Nuvectra from $18.00 to $23.00 and gave the stock a “market outperform” rating in a report on Wednesday, August 8th. Six analysts have rated the stock with a buy rating, Nuvectra has a consensus rating of “Buy” and a consensus price target of $23.50.
In other Nuvectra news, President Joseph Paul Hanchin sold 1,250 shares of the firm’s stock in a transaction dated Monday, August 20th. The stock was sold at an average price of $20.43, for a total value of $25,537.50. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 4.60% of the stock is currently owned by company insiders.
Nuvectra Company Profile
Nuvectra Corporation, a neuromodulation medical device company, develops and commercializes neurostimulation technology platform for the treatment of various disorders in neuroscience and clinical markets. It operates through two segments, Nuvectra and NeuroNexus. The company offers Algovita spinal cord stimulation system that is used for the treatment of chronic pain of the trunk and limbs.
Recommended Story: Asset Allocation and Your Retirement
Want to see what other hedge funds are holding NVTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nuvectra Corp (NASDAQ:NVTR).
Receive News & Ratings for Nuvectra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nuvectra and related companies with MarketBeat.com's FREE daily email newsletter.